IRIS
SASSO, Ferdinando Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.128
NA - Nord America 7.550
AS - Asia 7.049
SA - Sud America 1.073
AF - Africa 97
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.912
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 11.030
US - Stati Uniti d'America 7.372
SG - Singapore 2.318
CN - Cina 1.533
IE - Irlanda 1.353
IT - Italia 1.289
VN - Vietnam 1.053
HK - Hong Kong 1.036
BR - Brasile 891
GB - Regno Unito 525
DE - Germania 523
UA - Ucraina 410
KR - Corea 302
IN - India 265
SE - Svezia 217
FR - Francia 208
FI - Finlandia 151
JP - Giappone 140
TR - Turchia 101
GR - Grecia 99
CA - Canada 95
NL - Olanda 83
BD - Bangladesh 80
AR - Argentina 69
MX - Messico 48
AT - Austria 38
CZ - Repubblica Ceca 36
ID - Indonesia 36
PL - Polonia 31
ZA - Sudafrica 29
EC - Ecuador 28
ES - Italia 28
IQ - Iraq 27
BE - Belgio 24
CO - Colombia 23
PK - Pakistan 18
VE - Venezuela 18
MA - Marocco 16
LT - Lituania 14
CH - Svizzera 13
EG - Egitto 13
IR - Iran 13
UZ - Uzbekistan 12
DK - Danimarca 11
IL - Israele 11
PY - Paraguay 11
SA - Arabia Saudita 11
PE - Perù 10
PT - Portogallo 10
UY - Uruguay 10
AU - Australia 9
CL - Cile 9
MY - Malesia 9
SC - Seychelles 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
CR - Costa Rica 7
RO - Romania 7
AZ - Azerbaigian 6
JM - Giamaica 6
NP - Nepal 6
OM - Oman 6
EU - Europa 5
GE - Georgia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
SI - Slovenia 4
TH - Thailandia 4
BB - Barbados 3
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
EE - Estonia 3
HN - Honduras 3
KW - Kuwait 3
NG - Nigeria 3
PH - Filippine 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AN - Antille olandesi 1
AO - Angola 1
Totale 31.891
Salva come PNG Salva come JPEG
Città #
Moscow 4.007
Dublin 1.324
Singapore 1.079
San Jose 1.033
Hong Kong 1.004
Santa Clara 783
Chandler 692
Jacksonville 623
Ashburn 397
Ho Chi Minh City 341
Dallas 333
The Dalles 306
Hefei 291
Seoul 290
Naples 276
Hanoi 248
New York 196
Beijing 195
Bengaluru 189
Princeton 176
Medford 133
Munich 130
Roxbury 121
Los Angeles 118
Ann Arbor 108
Bremen 101
Boardman 90
São Paulo 82
Wilmington 82
Caserta 72
Woodbridge 72
Da Nang 67
San Mateo 65
Nanjing 63
Haiphong 57
Cambridge 54
Orem 53
Memphis 44
Amsterdam 43
Des Moines 43
Milan 43
Aversa 38
Rome 34
Houston 33
Chicago 32
Frankfurt am Main 32
Falkenstein 31
Düsseldorf 29
Napoli 29
Rio de Janeiro 29
Salerno 29
Montreal 28
Helsinki 27
Jinan 26
Mountain View 26
Tianjin 26
Tokyo 25
Brussels 24
Ercolano 24
Chennai 23
Atlanta 22
Brooklyn 22
Hải Dương 22
Nuremberg 22
Council Bluffs 21
Kunming 21
Mexico City 21
Biên Hòa 19
Bắc Ninh 19
Istanbul 19
Shanghai 19
Turku 19
Changsha 18
Shenyang 18
Belo Horizonte 17
Brno 17
London 17
Vienna 17
Boston 16
Seattle 16
Stockholm 16
Toronto 16
Brasília 15
Denver 15
Hillsboro 15
Nanchang 15
Norwalk 15
Ottawa 15
Paris 15
Phoenix 15
Warsaw 15
Giugliano In Campania 14
Florence 13
Lappeenranta 13
Porto Alegre 13
Thái Bình 13
Zhengzhou 13
Guangzhou 12
Johannesburg 12
Nha Trang 12
Totale 16.633
Salva come PNG Salva come JPEG
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 334
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 227
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 221
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. 206
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 204
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 198
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 187
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 186
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 184
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 184
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 182
Aminotrasferase activity and acarbose treatment in patients with type 2 diabetes 181
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 181
MiRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes 181
[Surgical treatment and interventional therapy in cerebral ischemia] 178
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 170
esults from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. 166
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 166
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 165
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 164
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 163
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 163
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 161
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 161
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 161
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 159
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 158
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 155
Predictors of early and late hepatocellular carcinoma recurrence 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 153
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 153
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 152
EFFECT OFTREATMENT WITH ACARBOSE,AN A-GLUCOSIDASE INHIBITOR ANDINSULIN IN PATIENT WITH NON-INSULIN-DEPENDENTDIABETESMELLITUS NON ALCOLIC LIVER CIRRHOSIS 152
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 152
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 152
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Aminotransferase activity and acarbose treatment in patients with type 2 diabetes 151
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 150
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 148
[Inhibitors of the platelet's receptor GPIIb/IIIA. Progress in the treatment of acute myocardial ischemia and future trends] 147
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 147
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 146
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment 145
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 144
Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha 141
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 141
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 140
Disfunzione renale nell’anziano: processo fisiologico o malattia? 140
Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome 139
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. 138
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 138
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 137
Effects of stress hyperglicemia on acute myocardial infarction 137
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 136
HCC and molecular targeting therapies: Back to the future 135
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 134
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 134
Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study 134
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 133
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 133
Multi-detector row CT for depicting anatomic features of cephalothoracopagus varieties: revised approach 133
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. 133
A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy 133
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 132
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels 132
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 132
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 132
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction. 131
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 130
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 130
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 129
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 129
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 129
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 129
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment 128
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome 128
Blocco di branca sinistra in lavoratori sottoposti a movimentazione manuale di carichi con basso rischio di patologie cardiache: applicazione della tomografia computerizzata multistrato 128
A case of anaplastic thyroid carcinoma with exceptional growth. 128
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 127
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 127
Totale 15.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.326 94 11 28 60 421 29 32 36 70 108 108 329
2022/20232.682 222 75 62 213 291 225 12 164 1.255 44 58 61
2023/20241.450 117 77 74 129 377 170 21 50 19 71 123 222
2024/20254.354 45 85 37 115 640 477 627 377 689 478 398 386
2025/202619.582 826 1.064 1.111 819 1.597 10.255 1.240 801 719 503 376 271
2026/202770 70 0 0 0 0 0 0 0 0 0 0 0
Totale 32.424